Repligen raises 2026 revenue outlook to $844M-$852M, citing BioLife acquisition

Repligen Corporation raised its 2026 revenue guidance to a range of $844 million to $852 million, citing strong third-quarter growth and its recent acquisition of BioLife Solutions. The acquisition makes BioLife Solutions part of the Repligen organization.

Detected & updated continuously · Source: Nebula